Get started
PfizerPfizerPfizer

Pfizer

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

PFE chart


Full chart

Key facts today

Pfizer's Braftovi gained FDA approval for use with Eli Lilly's Erbitux and other therapies for metastatic colorectal cancer with a BRAF V600E mutation, showing a 61% response rate in phase 3 trials.
Pfizer's stock has dropped 11% in 2024, contrasting sharply with Eli Lilly's 34% rise, reflecting notable performance differences amid ongoing uncertainties in the healthcare sector.
Analyze the impactAnalyze the impact

PFE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪146.04 B‬ USD
Dividend yield (indicated)
6.67%
Price to earnings Ratio (TTM)
34.64
Basic EPS (TTM)
0.75 USD
Net income (FY)
‪2.13 B‬ USD
Revenue (FY)
‪58.50 B‬ USD
Shares float
‪5.67 B‬
Beta (1Y)
0.06

Employees


Employees (FY)
‪88 K‬
Change (1Y)
‪+5 K‬ +6.02%
Revenue / Employee (1Y)
‪664.73 K‬ USD
Net income / Employee (1Y)
‪24.24 K‬ USD

About Pfizer


Sector
Health Technology
CEO
Albert Bourla
Headquarters
New York
Website
pfizer.com
Founded
1849
FIGI
BBG000BR2B91
Pfizer Inc is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PFE news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

PFE highest yielding bonds


US717081FA6
PFIZER 20/50
Yield to maturity
6.78%
Maturity date
May 28, 2050
XS173899459
PFIZER INC. 17/43
Yield to maturity
6.74%
Maturity date
Jun 15, 2043
US717081EZ2
PFIZER INC 20/40
Yield to maturity
6.54%
Maturity date
May 28, 2040
US717081EV1
PFIZER 19/49
Yield to maturity
6.21%
Maturity date
Mar 15, 2049
US717081ED1
PFIZER 16/46
Yield to maturity
6.18%
Maturity date
Dec 15, 2046
US717081EK5
PFIZER 18/48
Yield to maturity
6.17%
Maturity date
Sep 15, 2048
US717081DE0
PFIZER INC. 13/43
Yield to maturity
6.05%
Maturity date
Jun 15, 2043
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063
Yield to maturity
6.01%
Maturity date
May 19, 2063
PFER
PFIZER 19/39
Yield to maturity
5.95%
Maturity date
Mar 15, 2039
US717081DK6
PFIZER INC. 14/44
Yield to maturity
5.88%
Maturity date
May 15, 2044
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053
Yield to maturity
5.82%
Maturity date
May 19, 2053

Explore more bonds 

Sparks


Curated watchlists where PFE is featured.

See all sparks 

Frequently Asked Questions


The current price of PFE is 26.36 USD — it has increased by 2.29% in the past 24 hours. Watch Pfizer stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Pfizer stocks are traded under the ticker PFE.
PFE stock has risen by 4.03% compared to the previous week, the month change is a 5.15% rise, over the last year Pfizer has showed a −5.38% decrease.
We've gathered analysts' opinions on Pfizer future price: according to them, PFE price has a max estimate of 45.00 USD and a min estimate of 25.00 USD. Watch PFE chart and read a more detailed Pfizer stock forecast: see what analysts think of Pfizer and suggest that you do with its stocks.
PFE reached its all-time high on Dec 20, 2021 with the price of 61.71 USD, and its all-time low was 0.38 USD and was reached on Mar 14, 1968. View more price dynamics on PFE chart.
See other stocks reaching their highest and lowest prices.
PFE stock is 3.07% volatile and has beta coefficient of 0.06. Track Pfizer stock price on the chart and check out the list of the most volatile stocks — is Pfizer there?
Today Pfizer has the market capitalization of ‪146.04 B‬, it has increased by 4.76% over the last week.
Yes, you can track Pfizer financials in yearly and quarterly reports right on TradingView.
Pfizer is going to release the next earnings report on Feb 4, 2025. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are 1.06 USD per share, whereas the estimation was 0.61 USD resulting in a 72.53% surprise. The estimated earnings for the next quarter are 0.48 USD per share. See more details about Pfizer earnings.
Pfizer revenue for the last quarter amounts to ‪17.70 B‬ USD, despite the estimated figure of ‪14.92 B‬ USD. In the next quarter, revenue is expected to reach ‪17.28 B‬ USD.
PFE net income for the last quarter is ‪4.47 B‬ USD, while the quarter before that showed ‪24.00 M‬ USD of net income which accounts for ‪18.54 K‬% change. Track more Pfizer financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was 0.42 USD. As of today, Dividend Yield (TTM)% is 6.52%. Tracking Pfizer dividends might help you take more informed decisions.
Pfizer dividend yield was 5.73% in 2023, and payout ratio reached 439.41%. The year before the numbers were 3.14% and 29.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 21, 2024, the company has ‪88.00 K‬ employees. See our rating of the largest employees — is Pfizer on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer EBITDA is ‪16.70 B‬ USD, and current EBITDA margin is 17.99%. See more stats in Pfizer financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer stock shows the sell signal. See more of Pfizer technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.